Back to Search Start Over

P4.11E.12 First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial.

Authors :
Li, Y.-S.
Yang, J.-J.
Yu, Q.
Bu, Q.
Lin, L.
Ning, F.
Wu, G.
Lin, G.
Zang, A.
Ma, S.
Zhou, C.
Liu, A.
Zhao, Y.
Wang, C.
Yao, Y.
Han, G.
Zhao, J.
Pan, Y.
Sun, H.
Zheng, M.-M.
Source :
Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS399-S400, 2p
Publication Year :
2024

Details

Language :
English
ISSN :
15560864
Volume :
19
Issue :
10
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
180335452
Full Text :
https://doi.org/10.1016/j.jtho.2024.09.725